Arch Therapeutics Competitors and Similar CompaniesClear all

Arch Therapeutics's competitors and similar companies include Colorado Coagulation, Alafair Biosciences, Regenesis and Fisher & Paykel Healthcare.
Arch Therapeutics
Arch Therapeutics
Arch Therapeutics is a biotechnology company developing an innovative, elegant, and superior approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care.
Colorado Coagulation
Colorado Coagulation
Colorado Coagulation Consultants is a company that specializes in hemostasis testing.
Alafair Biosciences
Alafair Biosciences
Alafair Biosciences is a medical device company focused on developing and commercializing wound care products.
Regenesis
Regenesis
Regenesis Biomedical is a company focused on developing and marketing noninvasive regenerative medicine products.
Fisher & Paykel Healthcare
Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a company that designs, manufactures, and markets products for use in respiratory care, acute care, and the treatment of obstructive sleep apnea.
Founding Date
Founding Date
2006
Founding Date
1998
Founding Date
2011
Founding Date
1997
Founding Date
1971
Type
Type
Private
Type
Subsidiary
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Framingham, US HQ
Locations
Englewood, US HQ
Locations
Austin, US HQ
Locations
Scottsdale, US HQ
Locations
Auckland, NZ HQ
Melbourne, AU
Wien, AT
Sao Paulo, BR
Laval, CA
Guangzhou, CN
København, DK
see more
Employees
Employees
8
Employees
5
Employees
44
Employees
1071% decrease
Employees
6,978

Financial

Revenue (est.)
Revenue (est.)
$75.7k (FY, 2023)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$2b (FY, 2025)
Cost of goods
Cost of goods
$78.2k (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$610.2m (FY, 2025)
Gross profit
Gross profit
($2.4k) (FY, 2023)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$1.4b (FY, 2025)
Net income
Net income
($7m) (FY, 2023)
Net income
N/A
Net income
N/A
Net income
N/A
Net income
$377.2m (FY, 2025)

Funding

Latest funding round
Latest funding round
$ 3m (almost 11 years ago)
Latest funding round
N/A
Latest funding round
$ 7.2m (about 7 years ago)
Latest funding round
$ 5.3m (almost 15 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 5.9m
Total funding raised
N/A
Total funding raised
$ 12.7m
Total funding raised
$ 11.7m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Colorado Coagulation
HQ
Englewood, US

Colorado Coagulation Consultants is a company that specializes in hemostasis testing.

View company
Alafair Biosciences
HQ
Austin, US
Employees
44

Alafair Biosciences is a medical device company focused on developing and commercializing wound care products.

View company
Regenesis
HQ
Scottsdale, US
Employees
107↓ 1% decrease

Regenesis Biomedical is a company focused on developing and marketing noninvasive regenerative medicine products.

View company
Fisher & Paykel Healthcare
HQ
Auckland, NZ
Employees
6,978

Fisher & Paykel Healthcare is a company that designs, manufactures, and markets products for use in respiratory care, acute care, and the treatment of obstructive sleep apnea.

View company